Total synthesis of thyrsiferyl 23-acetate, a specific inhibitor of protein phosphatase 2A and an anti-leukemic inducer of apoptosis

Journal of the American Chemical Society

Volumn 122, Issue 38, 2000, Pages 9099-9108

  González, Isabel C ^a   Forsyth, Craig J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTILEUKEMIC AGENT; CHROMIUM DERIVATIVE; DEXTRO GLUTAMIC ACID; EPOXIDE; GERANIOL; NATURAL PRODUCT; ORGANOMETALLIC COMPOUND; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; TETRAHYDROPYRAN DERIVATIVE; THYRSIFEROL; THYRSIFERYL 18 ACETATE; THYRSIFERYL 18,23 DIACETATE; THYRSIFERYL 23 ACETATE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHEMICAL BINDING; CHEMICAL REACTION; CYCLIZATION; DERIVATIZATION; DRUG SYNTHESIS; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0039333274     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja000001r     Document Type: Article

References (96)

1. (a) Blunt, J. W.; Hartshorn, M. P.; McLennan, T. J.; Munro, M. H. G.; Robinson, W. T.; Yorke, S. C. Tetrahedron Lett. 1978, 69-72.
2. (b) González, A. G.; Arteaga, J. M.; Fernández, J. J.; Martín, J. D.; Norte, M.; Ruano, J. Z. Tetrahedron 1984, 40, 2751-2755.
3. (c) Sakemi, S.; Higa, T.; Jefford, C. W.; Bernardinelli, G. Tetrahedron Lett. 1986, 27, 4287-4290.
4. (d) Suzuki, T.; Takeda, S.; Suzuki, M.; Kurosawa, E.; Kato, A.; Imanaka, Y. Chem. Lett. 1987, 361-364.
5. (e) Suzuki, M.; Matsuo, Y.; Takahashi, Y.; Masuda, M. Chem. Lett. 1995, 1045-1046.
6. (f) Norte, M.; Fernández, J. J.; Souto, M. L.; García-Grávalos, M. D. Tetrahedron Lett. 1996, 37, 2671-2674.
7. (g) Norte, M.; Fernández, J. J.; Souto, M. L.; Gavín, J. A.; García-Grávalos, M. D. Tetrahedron 1997, 53, 3173-3178.
8. (h) Norte, M.; Fernández, J. J.; Souto, M. L. Tetrahedron 1997, 53, 4649-4654.
9. Suzuki, T.; Suzuki, M.; Furusaki, A.; Matsumoto, T.; Kato, A.; Imanaka, Y.; Kurosawa, E. Tetrahedron Lett. 1985, 26, 1329-1332.
10. Matsuzawa, S.-I.; Suzuki, T.; Suzuki, M.; Matsuda, A.; Kawamura, T.; Mizuno, Y.; Kikuchi, K. FEBS Lett. 1994, 356, 272-274.
11. Thyrsiferol (1b), 15(28)-anhydrothyrsiferyl-23-acetate (2a), thyrsiferyl 18-acetate (1c), and thyrsiferyl 15, 18, 23-triacetate.
12. (a) Matsuzawa, S.-I.; Kawamura, T.; Mitsuhashi, S.; Suzuki, T.; Matsuo, Y.; Suzuki, M.; Mizuno, Y.; Kikuchi, K. Bioorg. Med. Chem. 1999, 7, 381-387.
13. (b) Kikuchi, K.; Shima, H.; Mitsuhashi, S.; Suzuki, M.; Oikawa, H. Int. J. Mol. Med. 1999, 4, 395-401.
14. Schönthal, A. H. Front. Biosci. 1998, 3, 1262-1273.
15. (a) Uckun, F. M.; Evans, W. E.; Forsyth, C. J.; Waddick, K. G.; Ahlgren, L. T.; Chelstrom, L. M.; Burkhardt, A.; Bolen, J.; Myers, D. E. Science 1995, 267, 886-891.
16. (b) Myers, D. E.; Jun, X.; Waddick, K. G.; Chelstrom, L. M.; Forsyth, C. J.; Gunther, R.; Turner, N.; Bolen, J.; Uckun, F. M. Proc. Natl. Acad. Sci. USA 1995, 9575-9579.
17. 50 PP2A = 3.2-40 nM (Roberge, M.; Tudan, C.; Hung, S. M. F.; Harder, K. W.; Jirik, F. R.; Anderson, H. Cancer Res. 1994, 54, 6115-6121; Walsh, A. H.; Cheng, A.; Honkanen, R. E. FEBS Lett. 1997, 416, 230-234).
18. 50 PP2A = 3.2-40 nM (Roberge, M.; Tudan, C.; Hung, S. M. F.; Harder, K. W.; Jirik, F. R.; Anderson, H. Cancer Res. 1994, 54, 6115-6121; Walsh, A. H.; Cheng, A.; Honkanen, R. E. FEBS Lett. 1997, 416, 230-234).
19. 50 PP2A = 3.2-40 nM (Roberge, M.; Tudan, C.; Hung, S. M. F.; Harder, K. W.; Jirik, F. R.; Anderson, H. Cancer Res. 1994, 54, 6115-6121; Walsh, A. H.; Cheng, A.; Honkanen, R. E. FEBS Lett. 1997, 416, 230-234).
20. 50 PP2A = 3.2-40 nM (Roberge, M.; Tudan, C.; Hung, S. M. F.; Harder, K. W.; Jirik, F. R.; Anderson, H. Cancer Res. 1994, 54, 6115-6121; Walsh, A. H.; Cheng, A.; Honkanen, R. E. FEBS Lett. 1997, 416, 230-234).
21. Pec, M. K.; Hellan, M.; Moser-Their, K.; Fernández, J. J.; Souto, M. L.; Kubista, E. Int. J. Oncol. 1999, 14, 739-743.
22. (a) Pec, M. K.; Hellan, M.; Moser-Their, K.; Fernández, J. J.; Souto, M. L.; Kubista, E. Anticancer Res. 1997, 17, 4090.
23. (b) Pec, M. K.; Hellan, M.; Moser-Their, K.; Fernández, J. J.; Souto, M. L.; Kubista, E. Anticancer Res. 1998, 18, 3027-3032.
24. Fernández, J. J. ; Souto, M. L.; Norte, M. Bioorg. Med. Chem. 1998, 6, 2237-2243.
25. 50 1c = 464 nM. 2
26. (a) Broka, C. A.; Hu, L.; Lee, W. J.; Shen, T. Tetrahedron Lett. 1987, 28, 4993-4996.
27. (b) Broka, C. A.; Lin, Y.-T. J. Org. Chem. 1988, 53, 5876-5885.
28. (a) Hashimoto, N.; Kan, T.; Yanagiya, M.; Shirahama, H.; Matsumoto, T. Tetrahedron Lett. 1987, 28, 5665-5668.
29. (b) Hashimoto, N.; Kan, T.; Nozaki, K.; Yanagiya, M.; Shirahama, H.; Matsumoto, T. Tetrahedron Lett. 1988, 29, 1143-1144.
30. (c) Kan, T.; Hashimoto, M.; Yanagiya, M.; Shirahama, H. Tetrahedron Lett. 1988, 29, 5417-5418.
31. (d) Hashimoto, M.; Kan, T.; Nozaki, K.; Yanagiya, M.; Shirahama, H.; Matsumoto, T. J. Org. Chem. 1990, 55, 5088-5107.
32. Corey, E. J.; Ha, D.-C. Tetrahedron Lett. 1988, 29, 3171-3174.
33. González, I. C.; Forsyth, C. J. Org. Lett. 1999, 1, 319-322.
34. Takai, K.; Kuroda, T.; Nakatsukasa, S.; Oshima, K.; Nozaki, H. Tetrahedron Lett. 1985, 26, 5585-5588.
35. Aicher, T. D.; Kishi, Y. Tetrahedron Lett. 1987, 28, 3463-3466.
36. (a) Kennedy, R. M.; Tang, S. Tetrahedron Lett. 1992, 33, 3729-3732.
37. (b) Tang, S.; Kennedy, R. M. Tetrahedron Lett. 1992, 33, 5299-5302.
38. (c) Tang, S.; Kennedy, R. M. Tetrahedron Lett. 1992, 33, 5303-5306.
39. (d) Boyce, R. S.; Kennedy, R. M. Tetrahedron Lett. 1994, 35, 5133-5136.
40. (a) McDonald, F. E.; Towne, T. B. J. Org. Chem. 1995, 60, 5750-5751.
41. (b) Towne, T. B.; McDonald, F. E. J. Am. Chem. Soc. 1997, 119, 6022-6028.
42. 3CN to homoallylic alcohol 44.
43. (a) Jin, H.; Uenishi, J.-I.; Christ, W. J.; Kishi, Y. J. Am. Chem. Soc. 1986, 108, 5644-5646.
44. (b) Takai, K.; Tagashira, M.; Kuroda, T.; Oshima, K.; Utimoto, K.; Nozaki, H. J. Am. Chem. Soc. 1986, 108, 6048-6050.
45. Kato, T.; Ichinose, I.; Hosogai, T.; Kitahara, Y. Chem. Lett. 1976, 1187-1190.
46. Dittmer, D. C.; Discordia, R. P.; Zhang, Y.; Murphy, C. K.; Kumar, A.; Pepito, A. S.; Wang, Y. J. Org. Chem. 1993, 58, 718-731.
47. This approximate yield was obtained after purification of the crude mixture through a short silica gel column; further purification using MPLC caused loss of material.
48. The ratio was determined by GC using a DBS column (10m × 0.1 mm × 0.1 μm film thickness).
49. (a) Jung, M. E.; Lew, W. J. Org. Chem. 1991, 56, 1347-1349.
50. (b) Jung, M. E.; D'Amico, D. C.; Lew, W. Tetrahedron Lett. 1993, 34, 923-926.
51. (c) Jung, M. E.; Fahr, B. T.; D'Amico, D. C. J. Org. Chem. 1998, 63, 2982-2987.
52. Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masumune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765-5780.
53. (a) Hoye, T. R.; Kurth, M. J. J. Am. Chem. Soc. 1979, 101, 5065-5067.
54. (b) Hoye, T. R.; Kurth, M. J. Org. Chem. 1979, 44, 3461-3467.
55. Werner, J.; Bogert, M. T. J. Org. Chem. 1938, 3, 578-587.
56. Gassman, P. G.; Talley, J. J. Tetrahedron Lett. 1978, 3773-3776.
57. Förster, S.; Roos, J.; Effenberger, F.; Wajant, H.; Sprauer, A. Angew. Chem., Int. Ed. Engl. 1996, 35, 437-439.
58. (a) Huuhtanen, T. T.; Kanerva, L. T. Tetrahedron: Asymmetry 1992, 3, 1223-1226.
59. (b) Kiljunen, E.; Kanerva, L. T. Tetrahedron: Asymmetry 1996, 7, 1105-1116.
60. (c) Kiljunen, E.; Kanerva, L. T. Tetrahedron: Asymmetry 1997, 8, 1551-1557.
61. Menéndez, E.; Brieva, R.; Rebolledo, F.; Gotor, V. J. Chem. Soc., Chem. Commun. 1995, 989-990.
62. Nicolaou, K. C.; Prasad, C. V. C.; Somers, P. K.; Hwang, C.-K. J. Am. Chem. Soc. 1989, 111, 5330-5334.
63. The corresponding cis epoxides have been shown to disfavor the 6-endo mode of ring closure.
64. Suzuki, T.; Sato, O.; Hirama, M. Tetrahedron Lett. 1990, 31, 4747-4750.
65. (a) Mukai, C.; Sugimoto, Y.-I.; Ikeda, Y.; Hanaoka, M. Tetrahedron Lett. 1994, 35, 2183-2186.
66. (b) Mukai, C.; Ikeda, Y.; Sugimoto, Y.; Hanaoka, M. Tetrahedron Lett. 1994, 35, 2179-2182.
67. (a) Ravid, U.; Silverstein, R. M.; Smith, L. R. Tetrahedron 1978, 34, 1449-1452.
68. (b) Herdeis, C. Synthesis 1986, 232-233.
69. A diastereomer of the aldehyde 28 was prepared previously from L-glutamic acid: Nicolaou, K. C.; Reddy, K. J.; Skokotas, G.; Sato, F.; Xiao, X.-Y.; Hwang, C.-K. J. Am. Chem. Soc. 1993, 115, 3558-3575.
70. Corey, E. J.; Fuchs, P. Tetrahedron Lett. 1972, 3769-3772.
71. McIntosh, M. C.; Weinreb, S. M. J. Org. Chem. 1993, 58, 4823-4832.
72. For a precedent of this reaction in a cis dibromoalkenyl epoxide, see ref 35.
73. Lewis, M. D.; Cha, J. K.; Kishi, Y. J. Am. Chem. Soc. 1982, 104, 4976-4978.
74. Nicolaou, K. C.; Hwang, C.-K.; Nugiel, D. A. J. Am. Chem. Soc. 1989, 111, 4136-137
75. Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277-7287.
76. (a) Harmange, J.-C.; Figadère, B. Tetrahedron: Asymmetry 1993, 4, 1711-1754.
77. (b) Koert, U. Synthesis 1995, 115-132.
78. (a) Fukuyama, T.; Vranesic, B.; Negri, D. P.; Kishi, Y. Tetrahedron Lett. 1978, 31, 2741-2744.
79. (b) Nakata, T.; Schmid, G.; Vranesic, B.; Okigawa, M.; Smith-Palmer, T.; Kishi, Y. J. Am. Chem. Soc. 1978, 100, 2933-2935.
80. Hoeman, M. Z.; Agrios, K. A.; Aubé, J. Tetrahedron 1997, 53, 11087-11098.
81. Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768-2771.
82. The stereochemistry of tetrahydrofurans 40 was determined at the stage of the diacetate derivatives. The diacetate 46, derived from 40a, showed an NOE between protons al the C18 and C22 positions (Scheme 8).
83. Vidari, G.; Dapiaggi, A.; Zanoni, G.; Garlaschelli, L. Tetrahedron Lett. 1993, 34, 6485-6488.
84. The stereochemistry of the trans-tetrahydrofuran 41a was determined after protecting the two free hydroxyls with MOM groups, by detection of an NOE between protons at the C18 and C22 positions.
85. Ishihara, K.; Kubota, M.; Kurihara, H.; Yamamoto, H. J. Am. Chem. Soc. 1995, 117, 4413-4414.
86. Sinha, S. C.; Keinan, E.; Sinha, S. C. J. Am. Chem. Soc. 1998, 120, 9076-9077.
87. Sinha, S. C.; Sinha, A.; Sinha, S. C.; Keinan, E. J. Am. Chem. Soc. 1997, 119, 12014-12015.
88. Zhdanov, R. I.; Zhenodarova, S. M. Synthesis 1975, 222-245.
89. (a) Herrmann, W. A.; Thiel, W. R.; Kühn, F. E.; Fischer, R. W.; Kleine, M.; Herdtweck, E.; Scherer, W. Inorg. Chem. 1993, 32, 5188-5194.
90. (b) Edwards, P.; Wilkinson, G. J. J. Chem. Soc., Dalton Trans. 1984, 2695-2702.
91. Takai, K.; Nitta, K.; Utimoto, K. J. Am. Chem. Soc. 1986, 108, 7408-7410.
92. 1H NMR determination of the crude mixture it was possible to distinguish the two possible isomers in the ratio 3:1; however, the stereochemistry at the C15 was not assigned.
93. Lombardo, L. Tetrahedron Lett. 1982, 23, 4293.
94. Huang, H.; Forsyth, C. J. J. Org. Chem. 1995, 60, 5746-5757.
95. 1H NMR and HRMS data of 1b and 1a matched those previously reported: Blunt, J. W.; McCombs, J. D.; Munro, M. H. G.; Thomas, F. N. Magn. Reson. Chem. 1989, 27, 792-795 and ref 14d.
96. 1H NMR spectrum of semisynthetic 1c obtained from a natural sample of 1b, which was kindly provided by Prof. J. W. Blunt.